Company / Current Assets per Share
AXIM BIOTECHNOLOGIES, INC. Current Assets per Share History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.00
FY2023
5-year range
$0.00 / $0.04
FY2019-FY2023
Trend
+8.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share returned to growth in FY2023 after 2 years of decline, reaching $0.00.
Based on SEC 10-K filings.
0.00 in FY2023 with a 10-year CAGR of +24.0%.
Declined from $0.04 to $0.00 over the past 5 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -53.4%
- 10-Year CAGR
- +24.0%
Key checks
Key Insights
- In FY2023, current assets per share increased 8.0% year-over-year.
- Peak current assets per share was recorded in FY2017.
- Lowest current assets per share in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $0.00 | +8.0% |
| FY2022 | $0.00 | -98.0% |
| FY2018 | $0.04 | -7.9% |
| FY2017 | $0.04 | +16.1% |
| FY2016 | $0.03 | -3.3% |
| FY2015 | $0.04 | +37724.8% |
| FY2013 | $0.00 | -92.0% |
| FY2012 | $0.00 | -73.1% |
| FY2011 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026